• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对血液中环孢素分布相关变量的评估。

Assessment of variables contributing to cyclosporine distribution in blood.

作者信息

Broin S O, Clarke E, McCann S

机构信息

Department of Haematology, St. James's Hospital, Dublin.

出版信息

Ir J Med Sci. 1990 Sep-Dec;159(9-12):269-71. doi: 10.1007/BF02993609.

DOI:10.1007/BF02993609
PMID:2094690
Abstract

Factors which can account for the poor correlation between whole blood and plasma Cyclosporine (CsA) levels in patients on CsA prophylaxis are evaluated. The study took account of the influence of plasma separation procedures, and the sample haematocrit on CsA distribution in the blood of renal transplant patients (n = 35). CsA was measured using both specific and non-specific CsA radioimmunoassays. Significant negative correlations occurred between CsA distribution and the haematocrit, independently of the plasma separation procedure or the specificity of the assay. All results were lower when using the specific assay but a significantly higher percentage of CsA was measured in the plasma by specific assay compared to nonspecific assay when plasma was separated at both 22 degrees C (t-test, p less than 0.02) and at 37 degrees C, p less than 0.01). This may relate to the selective binding of CsA and its analogues by blood cells. This study is a prelude to the development of more consistent plasma separation procedures in the monitoring of this drug.

摘要

对环孢素(CsA)预防治疗患者全血与血浆中环孢素(CsA)水平相关性较差的影响因素进行了评估。该研究考虑了血浆分离程序以及样本血细胞比容对肾移植患者(n = 35)血液中CsA分布的影响。使用特异性和非特异性CsA放射免疫测定法对CsA进行测量。CsA分布与血细胞比容之间存在显著的负相关,与血浆分离程序或测定的特异性无关。使用特异性测定法时所有结果均较低,但当在22℃(t检验,p < 0.02)和37℃(p < 0.01)分离血浆时,与非特异性测定法相比,特异性测定法在血浆中测得的CsA百分比显著更高。这可能与血细胞对CsA及其类似物的选择性结合有关。本研究是开发在该药物监测中更一致的血浆分离程序的前奏。

相似文献

1
Assessment of variables contributing to cyclosporine distribution in blood.对血液中环孢素分布相关变量的评估。
Ir J Med Sci. 1990 Sep-Dec;159(9-12):269-71. doi: 10.1007/BF02993609.
2
A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.肾移植后环孢素浓度与其治疗效果及毒性关系的前瞻性研究。
Br J Clin Pharmacol. 1990 Sep;30(3):443-52. doi: 10.1111/j.1365-2125.1990.tb03796.x.
3
Determination of cyclosporine by a competitive binding assay with cyclophilin.采用与亲环蛋白的竞争性结合试验测定环孢素。
Clin Chem. 1991 Mar;37(3):403-10.
4
Assessment of cyclosporin A in whole blood and plasma in five patients with different hematocrits.对五名血细胞比容不同的患者的全血和血浆中环孢素A的评估。
Ther Drug Monit. 1985;7(1):61-5. doi: 10.1097/00007691-198503000-00010.
5
Effect of hematocrit on cyclosporine (cyclosporin A) in whole blood and plasma of renal-transplant patients.血细胞比容对肾移植患者全血和血浆中环孢素(环孢素A)的影响。
Clin Chem. 1985 Mar;31(3):410-2.
6
Monitoring of cyclosporin A levels with radioimmunoassay in renal transplant recipients: comparison of monospecific and nonspecific assays.肾移植受者中环孢素A水平的放射免疫测定监测:单特异性和非特异性测定的比较。
J Formos Med Assoc. 1993 Nov;92(11):948-52.
7
Cyclosporine metabolite disposition after oral administration in pretransplant end-stage renal disease patients.肾移植前终末期肾病患者口服环孢素后其代谢产物的处置情况
Transplant Proc. 1988 Apr;20(2 Suppl 2):499-508.
8
The management of heart transplant recipients treated with cyclosporine in Ireland: monitoring of cyclosporine concentrations in blood.爱尔兰接受环孢素治疗的心脏移植受者的管理:血液中环孢素浓度的监测。
Ir J Med Sci. 1990 Sep-Dec;159(9-12):272-4. doi: 10.1007/BF02993610.
9
Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: effects of binding and metabolism.肾移植受者长期使用环孢素的药代动力学变化:结合与代谢的影响。
Clin Pharmacol Ther. 1989 Jan;45(1):41-8. doi: 10.1038/clpt.1989.7.
10
Immunopharmacodynamic profiles in children with renal allografts receiving cyclosporine therapy.接受环孢素治疗的肾移植儿童的免疫药效学特征。
Am J Kidney Dis. 1988 Aug;12(2):104-9. doi: 10.1016/s0272-6386(88)80003-9.

本文引用的文献

1
A radioimmunoassay to measure cyclosporin A in plasma and serum samples.一种用于测量血浆和血清样本中环孢素A的放射免疫分析方法。
J Immunoassay. 1981;2(1):19-32. doi: 10.1080/01971528108062989.
2
In vitro stability of cyclosporin A.环孢素A的体外稳定性
J Clin Pathol. 1983 Jun;36(6):720-1. doi: 10.1136/jcp.36.6.720.
3
Cyclosporin concentrations in whole blood and plasma.全血和血浆中环孢素的浓度。
Clin Chem. 1984 May;30(5):817.
4
Effects of sample preparation on concentrations of cyclosporin A measured in plasma.样品制备对血浆中所测环孢素A浓度的影响。
Clin Chem. 1984 Nov;30(11):1812-4.
5
Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood.脂蛋白和红细胞在环孢素A于血液中的体外结合及分布中的作用。
J Pharm Pharmacol. 1982 Nov;34(11):715-8. doi: 10.1111/j.2042-7158.1982.tb06206.x.
6
Assessment of cyclosporin A in whole blood and plasma in five patients with different hematocrits.对五名血细胞比容不同的患者的全血和血浆中环孢素A的评估。
Ther Drug Monit. 1985;7(1):61-5. doi: 10.1097/00007691-198503000-00010.
7
Effect of hematocrit on cyclosporine (cyclosporin A) in whole blood and plasma of renal-transplant patients.血细胞比容对肾移植患者全血和血浆中环孢素(环孢素A)的影响。
Clin Chem. 1985 Mar;31(3):410-2.
8
The United Kingdom Cyclosporin Quality Assessment Scheme.英国环孢素质量评估计划。
Ther Drug Monit. 1986;8(2):200-4. doi: 10.1097/00007691-198606000-00013.
9
Cyclosporine concentrations in plasma at 37 degrees C are not predictable from concentrations measured in whole blood at room temperature.37摄氏度时血浆中的环孢素浓度无法根据室温下全血中测得的浓度来预测。
Clin Chem. 1988 Mar;34(3):597.
10
Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring.环孢素监测中的关键问题:环孢素监测特别工作组报告
Clin Chem. 1987 Jul;33(7):1269-88.